معرفی
Shuibing Chen is a Professor at the Graduate School of Medical Sciences, Weill Cornell Medicine, where he leads the Chen Laboratory. His research is centered on manipulating human pluripotent stem cells (hPSCs), including embryonic and induced pluripotent stem cells, to generate functional tissues and organs for regenerative medicine and disease modeling.
The lab integrates stem cell biology, developmental biology, chemical biology, and tissue engineering to advance translational research. Key research areas include:
- Directed differentiation of hPSCs into functional cell types
- Generation of organoids for modeling human diseases
- High-throughput chemical screening to control stem cell fate
- Development of 'disease in a dish' platforms
- Applications in diabetes, cardiac disorders, and viral infections such as SARS-CoV-2
Dr. Chen's work combines gene targeting, organoid systems, and humanized mouse models to dissect genetic and environmental contributions to disease progression, enabling drug screening and precision therapy development.
He is affiliated with the Cell & Developmental Biology PhD program and contributes to training the next generation of scientists in stem cell and developmental biology.
Scientific Awards
- No awards listed in the provided text.
Dr. Chen’s research has significant implications for regenerative medicine and drug discovery, particularly through scalable organoid models adaptable to high-throughput screening. While specific grants and advising relationships are not detailed, his lab actively engages in interdisciplinary projects aimed at bridging basic science with clinical translation. The Chen Laboratory is a key contributor to Weill Cornell’s efforts in advancing stem cell-based therapeutics and disease modeling.
The lab has developed innovative models related to:
- Immuno-cardiac organoids
- iPSC-based GWAS for disease mechanisms
- Islet cell responses to SARS-CoV-2
- Pacemaker cell function and viral interactions
